Heron Therapeutics, Inc.
HRTXNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $56.38M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.26$1.58
- Volume (live)
- -
- Avg. volume (3M)
- 2.50M
Heron Therapeutics (HRTX) Stock Price & Financial Analysis
Heron Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.29 - $0.35 |
|---|---|
| 52-Week High | $1.58 |
| 52-Week Low | $0.26 |
| Open | $0.34 |
| Volume (last close) | 4.74M |
| Average Volume (3M) | 2.50M |
| Revenue (TTM) | 151.18M |
|---|---|
| Net Income (TTM) | -34.05M |
| Free Cash Flow (TTM) | -12.13M |
| EPS (TTM) | −$0.19 |
| Profit Margin | -22.52% |
| Operating Margin | -7.19% |
| Return on Equity (ROE) | -492.89% |
| Debt to Equity | 20.68 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 56.38M |
|---|---|
| Shares Outstanding | 190.34M |
| Price to Sales (P/S) | 0.37 |
| Price to Book (P/B) | 8.16 |
| EV/EBITDA | -7.45 |
| 50-Day MA | $0.33 |
|---|---|
| 200-Day MA | $0.74 |
| 1-Year Change | −75.11% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Heron Therapeutics at a Glance
As of the Oct 22, 2026 close, Heron Therapeutics (HRTX) has a market capitalization of $56.38M. The stock trades at 0.4× sales. Over the trailing twelve months it lost $34.05M on revenue of $151.18M and burned $12.13M of free cash flow. Revenue grew 1.0% year over year.
As of its latest reported balance sheet, it holds $20.72M in cash and securities against $142.85M of debt, a net debt position of $122.13M.
Heron Therapeutics does not currently pay a dividend.
The share price is down 75.1% over the past year. At $0.30 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.26 to $1.57, below its 200-day moving average of $0.74.
Frequently Asked Questions About Heron Therapeutics
What is the current stock price for HRTX?
As of the Oct 22, 2026 close, HRTX stock trades at $0.30. The 52-week range is $0.26–$1.58, with a day range of $0.29–$0.35.
What is the P/E ratio for HRTX?
The P/E ratio (Price-to-Earnings) for HRTX is shown in the Key Statistics section. This valuation metric helps compare Heron Therapeutics, Inc. to industry peers.
Does HRTX pay dividends?
Heron Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for HRTX?
Analyst ratings and recommendations for HRTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of HRTX?
As of the Oct 22, 2026 close, Heron Therapeutics's market capitalization is $56.4M, classifying it as a micro-cap company. Heron Therapeutics operates in the Healthcare sector within the Biotechnology industry.